High altitude cerebral and pulmonary edema

Area of Science:

• Medical Science
• Physiology
• Environmental Health

Background:

• Altitude illness encompasses acute mountain sickness (AMS), high altitude cerebral edema (HACE), and high altitude pulmonary edema (HAPE).
• AMS and HACE are often viewed as a progression of the same condition.
• Recent research has yielded significant findings regarding HAPE's pathophysiology and prevention.

Purpose of the Study:

• To review historical facts, novel pathophysiological processes, and clinical aspects of altitude illness.
• To provide a detailed examination of HAPE, including recent advancements.
• To discuss newer aspects like dehydration as a risk factor, angiogenesis in cerebral edema, and vulnerable populations.

Main Methods:

• Literature review focusing on altitude illness, particularly HAPE.
• Synthesis of historical data, current research on pathophysiology, and clinical observations.
• Inclusion of treatment and prevention guidelines.

Main Results:

• Discussion of the continuum between AMS and HACE.
• Detailed exploration of HAPE pathophysiology and prevention.
• Consideration of dehydration, angiogenesis, and genetic factors in altitude sickness susceptibility.

Conclusions:

• Altitude illness is a complex condition requiring sophisticated diagnosis and management.
• Recent findings offer improved understanding and strategies for preventing and treating HAPE.
• Further research into genetic predispositions and novel risk factors is warranted.